LADENBURG THALMANN FINANCIAL SERVICES INC. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2019$10,000
+66.7%
3,1690.0%0.00%
Q3 2019$6,000
-33.3%
3,169
+0.3%
0.00%
Q2 2019$9,000
-86.6%
3,161
-82.6%
0.00%
-100.0%
Q1 2019$67,000
+28.8%
18,1250.0%0.00%
Q4 2018$52,000
+4.0%
18,125
-5.3%
0.00%
Q3 2018$50,000
-29.6%
19,142
-20.7%
0.00%
-100.0%
Q2 2018$71,0000.0%24,1420.0%0.00%0.0%
Q1 2018$71,000
+22.4%
24,142
+14.9%
0.00%0.0%
Q4 2017$58,000
-18.3%
21,0170.0%0.00%0.0%
Q3 2017$71,000
+36.5%
21,0170.0%0.00%0.0%
Q2 2017$52,000
+8.3%
21,0170.0%0.00%0.0%
Q1 2017$48,000
+1500.0%
21,017
+1329.7%
0.00%
Q4 2016$3,000
-92.7%
1,470
-87.9%
0.00%
-100.0%
Q3 2016$41,000
+2.5%
12,170
-3.5%
0.00%0.0%
Q2 2016$40,0000.0%12,613
+6.3%
0.00%0.0%
Q1 2016$40,000
-34.4%
11,869
-31.3%
0.00%0.0%
Q4 2015$61,000
-39.6%
17,275
-14.0%
0.00%
-50.0%
Q3 2015$101,000
-16.5%
20,083
+5.9%
0.00%0.0%
Q2 2015$121,000
-8.3%
18,956
+0.1%
0.00%
-33.3%
Q1 2015$132,000
-1.5%
18,934
+8.8%
0.00%0.0%
Q4 2014$134,000
+50.6%
17,395
+45.6%
0.00%
+50.0%
Q3 2014$89,000
-16.8%
11,949
+7.7%
0.00%
-33.3%
Q2 2014$107,000
-0.9%
11,092
-14.9%
0.00%0.0%
Q1 2014$108,000
-9.2%
13,036
-7.7%
0.00%
-25.0%
Q4 2013$119,000
-4.8%
14,116
-9.3%
0.00%0.0%
Q3 2013$125,000
+2.5%
15,570
-1.0%
0.00%0.0%
Q2 2013$122,00015,7230.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Silver Point Capital L.P. 23,783,273$58,745,0006.82%
Park West Asset Management LLC 14,397,212$35,561,0000.74%
GABELLI & Co INVESTMENT ADVISERS, INC. 633,700$1,565,0000.24%
JBF Capital, Inc. 543,990$1,344,0000.22%
Context Capital Management, LLC 465,172$1,149,0000.16%
Bellecapital International Ltd. 108,025$267,0000.09%
FNY Investment Advisers, LLC 100,000$247,0000.07%
WINTON GROUP Ltd 291,360$720,0000.05%
Freedom Investment Management, Inc. 54,735$135,0000.02%
HANCOCK WHITNEY CORP 187,757$464,0000.02%
View complete list of PDL BIOPHARMA INC shareholders